Gross Margin
25.17%vs Specialty Chemicals peers Updated Nov 20, 2026Profit Margin
10.47%vs Specialty Chemicals peers Updated Nov 20, 2026Operating Margin
10.69%vs Specialty Chemicals peers Updated Nov 20, 2026Return on Assets (TTM)
3.15%vs Specialty Chemicals peers Updated Nov 20, 2026Return on Equity (TTM)
6.01%vs Specialty Chemicals peers Updated Nov 20, 2026Revenue (TTM)
2.02BCNY302.61M · vs all stocks (USD) Updated Nov 20, 2026Revenue per Share (TTM)
5.61CNYUpdated Nov 20, 2026Quarterly Revenue Growth
8.30%vs Specialty Chemicals peers Updated Nov 20, 2026Gross Profit (TTM)
519.92MCNY77.91M · vs all stocks (USD) Updated Nov 20, 2026EBITDA (TTM)
265.08MCNY39.73M · vs all stocks (USD) Updated Nov 20, 2026Net Income (TTM)
211.49MCNY31.69M · vs all stocks (USD) Updated Nov 20, 2026Quarterly Earnings Growth (YoY)
-0.70%vs Specialty Chemicals peers Updated Nov 20, 2026Operating Cash Flow (TTM)
287.36MCNY43.06M · vs all stocks (USD) Updated Nov 20, 2026Levered Free Cash Flow (TTM)
-1.22BCNY-182.47M · vs all stocks (USD) Updated Nov 20, 2026Trailing Annual Dividend Rate
0.1000CNYUpdated Nov 20, 2026Trailing Annual Dividend Yield
0.73%Updated Nov 20, 20265-Year Average Dividend Yield
0.57%Updated Nov 20, 2026Payout Ratio
34.05%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 17.24%.Updated Nov 20, 2026Minority Interest (Equity)
36.13MCNYFY2025 · Dec 31, 2025Revenue
1.90BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.42BCNYFY2025 · Dec 31, 2025Gross Profit
487.16MCNYFY2025 · Dec 31, 2025Operating Income
234.34MCNY35.12M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
249.92MCNYFY2025 · Dec 31, 2025Income Tax Expense
20.90MCNYFY2025 · Dec 31, 2025Net Income
229.02MCNYFY2025 · Dec 31, 2025EBIT
259.42MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
428.73MCNYFY2025 · Dec 31, 2025Research & Development
91.55MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
71.83MCNYFY2025 · Dec 31, 2025Other Operating Expenses
15.82MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
40.63MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
9.49MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.6319CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.6319CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
361.13MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
361.13MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
229.02MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-822.87KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
78.70MCNYFY2025 · Dec 31, 2025Free Cash Flow
-201.44MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
359.84MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
229.02MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-23.76MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-56.07MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-70.48MCNYFY2025 · Dec 31, 2025Capital Expenditures
-280.14MCNYFY2025 · Dec 31, 2025Net Acquisitions
-19.00MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.54MCNYFY2025 · Dec 31, 2025Sale of Investments
317.34KCNYFY2025 · Dec 31, 2025Other Investing Activity
188.94MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-111.42MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
535.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-420.50MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-92.37MCNYFY2025 · Dec 31, 2025Other Financing Charges
27.69MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
49.82MCNYFY2025 · Dec 31, 2025